Biosimilar uptake of filgrastim and impact on spending in Medicare Part D from 2015 to 2019.

67Background: The introduction of a filgrastim biosimilar in 2014 was associated with substantial cost savings in Medicare Part B and Medicaid programs. However, Medicare Part D is unique since it ...